Cerner Corp. (NASDAQ:CERN) has been given a consensus rating of “Buy” by the twenty-six ratings firms that are currently covering the firm. Ten investment analysts have rated the stock with a hold recommendation, fifteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $66.44.

CERN has been the subject of a number of recent analyst reports. Bank of America Corp. initiated coverage on Cerner Corp. in a report on Monday, September 19th. They set a “neutral” rating and a $67.00 price target for the company. Zacks Investment Research raised Cerner Corp. from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a report on Tuesday, October 4th. Raymond James Financial Inc. downgraded Cerner Corp. from an “outperform” rating to a “market perform” rating and set a $64.57 price target for the company. in a report on Tuesday, July 5th. Barclays PLC lifted their price target on Cerner Corp. from $55.00 to $67.00 and gave the stock an “overweight” rating in a report on Wednesday, August 3rd. Finally, Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $67.00 price target on shares of Cerner Corp. in a report on Friday.

In related news, Vice Chairman Clifford W. Illig sold 325,705 shares of the company’s stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $65.10, for a total value of $21,203,395.50. Following the sale, the insider now owns 6,652,392 shares of the company’s stock, valued at approximately $433,070,719.20. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Linda M. Dillman sold 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $64.68, for a total value of $388,080.00. The disclosure for this sale can be found here. 13.20% of the stock is owned by corporate insiders.

Large investors have recently bought and sold shares of the stock. Washington Trust Bank raised its stake in Cerner Corp. by 0.4% in the third quarter. Washington Trust Bank now owns 3,664 shares of the company’s stock worth $226,000 after buying an additional 13 shares during the last quarter. Alpha Windward LLC raised its stake in Cerner Corp. by 2.2% in the second quarter. Alpha Windward LLC now owns 2,061 shares of the company’s stock worth $121,000 after buying an additional 44 shares during the last quarter. Ranger Investment Management L.P. raised its stake in Cerner Corp. by 1.1% in the second quarter. Ranger Investment Management L.P. now owns 4,580 shares of the company’s stock worth $268,000 after buying an additional 50 shares during the last quarter. Pacer Advisors Inc. raised its stake in Cerner Corp. by 0.5% in the second quarter. Pacer Advisors Inc. now owns 10,226 shares of the company’s stock worth $599,000 after buying an additional 55 shares during the last quarter. Finally, Bartlett & Co. LLC raised its stake in Cerner Corp. by 0.3% in the second quarter. Bartlett & Co. LLC now owns 18,907 shares of the company’s stock worth $1,108,000 after buying an additional 57 shares during the last quarter. 81.41% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Cerner Corp. (NASDAQ:CERN) opened at 60.83 on Thursday. Cerner Corp. has a 12-month low of $49.59 and a 12-month high of $68.31. The company’s 50-day moving average price is $62.45 and its 200 day moving average price is $59.54. The firm has a market capitalization of $20.54 billion, a price-to-earnings ratio of 33.40 and a beta of 0.79.

Cerner Corp. (NASDAQ:CERN) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $0.58 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.01. The company earned $1.22 billion during the quarter, compared to the consensus estimate of $1.21 billion. Cerner Corp. had a return on equity of 18.57% and a net margin of 13.53%. Cerner Corp.’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.52 EPS. On average, equities research analysts forecast that Cerner Corp. will post $2.36 EPS for the current fiscal year.

Cerner Corp. Company Profile

Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.

5 Day Chart for NASDAQ:CERN

Receive News & Stock Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related stocks with our FREE daily email newsletter.